IMVT Markets Signal, Research & Overview

Timing · 1D

Technicals

Summary

Neutral

50

11 5 11

Oscillators

Neutral

45

3 5 2

Moving averages

Neutral

53

8 0 9

Indicator details →

Signal & events

Model signalUnavailable

EarningsAug 6, 2026

CatalystsData pending

Signal history →Earnings & events →

Company data

Fundamentals

Full fundamentals →

Valuation

Market Cap$7.93B

Growth and income

Eps-2.77

Free Cash Flow$-234.28M

Net Income$-505.61M

Profitability

Ebitda$-532.49M

Balance sheet

Free Cash Flow$-234.28M

Total Assets$957.01M

Total Liabilities$104.42M

Dividends

Payout Ratio0.00%

Trailing Annual Dividend Rate0

Trailing Annual Dividend Yield0.00%

Financial statements →Valuation history →Ownership & capital →

Observed associations

Relationships

View all →

ROIVROIVANT SCIENCES LTD+0.00%Market co-movement · Residual co-movement · Directional relationship KURAKURA ONCOLOGY INC+0.00%Market co-movement · Residual co-movement SYRESPYRE THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement · Directional relationship NRIXNURIX THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement DYNDYNE THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement

RelationshipsLoading

IMMUNOVANT INC

Quick Read

Technicals

Fundamentals

Valuation

Growth and income

Profitability

Balance sheet

Dividends

Relationships

Relationships